Victory Capital Management Inc Igm Biosciences, Inc. Transaction History

Victory Capital Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$15.45 - $26.02 $150,637 - $253,695	9,750 Added 12.12%	90,200 $1.53 Million
Q3 2022 Nov 02, 2022	SELL	$15.42 - $27.01 $12,536 - $21,959	-813 Reduced 1.0%	80,450 $1.83 Million
Q2 2022 Aug 01, 2022	BUY	$13.27 - $25.5 $940,829 - $1.81 Million	70,899 Added 684.09%	81,263 $1.47 Million
Q1 2022 May 04, 2022	SELL	$13.42 - $29.73 $285,134 - $631,673	-21,247 Reduced 67.21%	10,364 $173,000
Q4 2021 Feb 07, 2022	SELL	$27.59 - $66.39 $69,747 - $167,833	-2,528 Reduced 7.41%	31,611 $927,000
Q3 2021 Nov 02, 2021	SELL	$65.76 - $90.65 $221,545 - $305,399	-3,369 Reduced 8.98%	34,139 $2.25 Million
Q2 2021 Aug 03, 2021	SELL	$57.98 - $96.6 $133,527 - $222,469	-2,303 Reduced 5.78%	37,508 $3.12 Million
Q1 2021 May 04, 2021	BUY	$71.56 - $121.23 $565,109 - $957,353	7,897 Added 24.74%	39,811 $3.05 Million
Q4 2020 Feb 01, 2021	BUY	$47.41 - $115.03 $849,444 - $2.06 Million	17,917 Added 128.01%	31,914 $2.82 Million
Q3 2020 Nov 09, 2020	BUY	$43.0 - $84.01 $601,871 - $1.18 Million	13,997 New	13,997 $1.03 Million
Q2 2020 Aug 07, 2020	SELL	$51.3 - $75.21 $62,432 - $91,530	-1,217 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$31.51 - $73.75 $77,892 - $182,310	-2,472 Reduced 67.01%	1,217 $68,000
Q4 2019 Feb 06, 2020	BUY	$17.25 - $49.51 $42,176 - $121,051	2,445 Added 196.54%	3,689 $141,000
Q4 2019 Feb 04, 2020	BUY	$17.25 - $49.51 $21,459 - $61,590	1,244 New	1,244 $42,000

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $189M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.